SMRT-depleted conventional DCs maintain inflammation despite lower glycolysis via mTOR signalling and succinate oxidation

Abstract Inflammatory diseases implicate a synchronised immune-metabolic rewiring to maintain homeostasis. The regulatory mechanisms governing the transcriptional control of immune-centric metabolic adjustments in dendritic cells (DCs) remains elusive. Recently we reported that Ncor2 (SMRT) loss of...

Full description

Saved in:
Bibliographic Details
Main Authors: Kaushik Sen, Rashmirekha Pati, Gyan Prakash Mishra, Subhasish Prusty, Sourya Prakash Nayak, Archana Tripathy, Shweta Chaudhary, Atimukta Jha, Arunita Patra, Priti Meena, Shaktiprasad Mishra, Ranjan Kumar Nanda, Alok Kumar Mantri, Bhawna Gupta, Sunil K. Raghav
Format: Article
Language:English
Published: Nature Portfolio 2024-12-01
Series:npj Metabolic Health and Disease
Online Access:https://doi.org/10.1038/s44324-024-00034-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850135845620678656
author Kaushik Sen
Rashmirekha Pati
Gyan Prakash Mishra
Subhasish Prusty
Sourya Prakash Nayak
Archana Tripathy
Shweta Chaudhary
Atimukta Jha
Arunita Patra
Priti Meena
Shaktiprasad Mishra
Ranjan Kumar Nanda
Alok Kumar Mantri
Bhawna Gupta
Sunil K. Raghav
author_facet Kaushik Sen
Rashmirekha Pati
Gyan Prakash Mishra
Subhasish Prusty
Sourya Prakash Nayak
Archana Tripathy
Shweta Chaudhary
Atimukta Jha
Arunita Patra
Priti Meena
Shaktiprasad Mishra
Ranjan Kumar Nanda
Alok Kumar Mantri
Bhawna Gupta
Sunil K. Raghav
author_sort Kaushik Sen
collection DOAJ
description Abstract Inflammatory diseases implicate a synchronised immune-metabolic rewiring to maintain homeostasis. The regulatory mechanisms governing the transcriptional control of immune-centric metabolic adjustments in dendritic cells (DCs) remains elusive. Recently we reported that Ncor2 (SMRT) loss of function in DCs potentiates strong inflammation. We found that SMRT depletion in DCs triggers a metabolic shift resulting in sustained and strong inflammation despite reduced glycolysis. This is in contrast to the widely accepted notion that glycolytic pathway activation is essential for inducing inflammation. Downregulation of mTOR emerged as a pivotal factor in attenuating the glycolytic rate. Significant metabolic alterations led to rewiring of the TCA-cycle by triggering anaplerotic glutamine catabolism and promoting succinate oxidation, thereby sustaining the inflammatory potential. Simultaneous treatment with succinate transport inhibitor DEBM and mTOR inducer Mhy1485 remarkably suppressed inflammation ex vivo and in vivo. Our findings also depicted an inverse correlation between SMRT levels with human autoimmune diseases.
format Article
id doaj-art-2cb071a283f34025aa92dc5600e877d5
institution OA Journals
issn 2948-2828
language English
publishDate 2024-12-01
publisher Nature Portfolio
record_format Article
series npj Metabolic Health and Disease
spelling doaj-art-2cb071a283f34025aa92dc5600e877d52025-08-20T02:31:17ZengNature Portfolionpj Metabolic Health and Disease2948-28282024-12-012111610.1038/s44324-024-00034-1SMRT-depleted conventional DCs maintain inflammation despite lower glycolysis via mTOR signalling and succinate oxidationKaushik Sen0Rashmirekha Pati1Gyan Prakash Mishra2Subhasish Prusty3Sourya Prakash Nayak4Archana Tripathy5Shweta Chaudhary6Atimukta Jha7Arunita Patra8Priti Meena9Shaktiprasad Mishra10Ranjan Kumar Nanda11Alok Kumar Mantri12Bhawna Gupta13Sunil K. Raghav14Immunogenomics & Systems Biology Lab, Institute of Life Sciences (ILS)Immunogenomics & Systems Biology Lab, Institute of Life Sciences (ILS)Immunogenomics & Systems Biology Lab, Institute of Life Sciences (ILS)Immunogenomics & Systems Biology Lab, Institute of Life Sciences (ILS)Immunogenomics & Systems Biology Lab, Institute of Life Sciences (ILS)Immunogenomics & Systems Biology Lab, Institute of Life Sciences (ILS)Translational Health Group, International Centre for Genetic Engineering and Biotechnology (ICGEB)Immunogenomics & Systems Biology Lab, Institute of Life Sciences (ILS)Immunogenomics & Systems Biology Lab, Institute of Life Sciences (ILS)Department of Nephrology, All India Institute of Medical SciencesImmunogenomics & Systems Biology Lab, Institute of Life Sciences (ILS)Translational Health Group, International Centre for Genetic Engineering and Biotechnology (ICGEB)Department of Gastroenterology, Utkal HospitalKalinga Institute of Industrial TechnologyImmunogenomics & Systems Biology Lab, Institute of Life Sciences (ILS)Abstract Inflammatory diseases implicate a synchronised immune-metabolic rewiring to maintain homeostasis. The regulatory mechanisms governing the transcriptional control of immune-centric metabolic adjustments in dendritic cells (DCs) remains elusive. Recently we reported that Ncor2 (SMRT) loss of function in DCs potentiates strong inflammation. We found that SMRT depletion in DCs triggers a metabolic shift resulting in sustained and strong inflammation despite reduced glycolysis. This is in contrast to the widely accepted notion that glycolytic pathway activation is essential for inducing inflammation. Downregulation of mTOR emerged as a pivotal factor in attenuating the glycolytic rate. Significant metabolic alterations led to rewiring of the TCA-cycle by triggering anaplerotic glutamine catabolism and promoting succinate oxidation, thereby sustaining the inflammatory potential. Simultaneous treatment with succinate transport inhibitor DEBM and mTOR inducer Mhy1485 remarkably suppressed inflammation ex vivo and in vivo. Our findings also depicted an inverse correlation between SMRT levels with human autoimmune diseases.https://doi.org/10.1038/s44324-024-00034-1
spellingShingle Kaushik Sen
Rashmirekha Pati
Gyan Prakash Mishra
Subhasish Prusty
Sourya Prakash Nayak
Archana Tripathy
Shweta Chaudhary
Atimukta Jha
Arunita Patra
Priti Meena
Shaktiprasad Mishra
Ranjan Kumar Nanda
Alok Kumar Mantri
Bhawna Gupta
Sunil K. Raghav
SMRT-depleted conventional DCs maintain inflammation despite lower glycolysis via mTOR signalling and succinate oxidation
npj Metabolic Health and Disease
title SMRT-depleted conventional DCs maintain inflammation despite lower glycolysis via mTOR signalling and succinate oxidation
title_full SMRT-depleted conventional DCs maintain inflammation despite lower glycolysis via mTOR signalling and succinate oxidation
title_fullStr SMRT-depleted conventional DCs maintain inflammation despite lower glycolysis via mTOR signalling and succinate oxidation
title_full_unstemmed SMRT-depleted conventional DCs maintain inflammation despite lower glycolysis via mTOR signalling and succinate oxidation
title_short SMRT-depleted conventional DCs maintain inflammation despite lower glycolysis via mTOR signalling and succinate oxidation
title_sort smrt depleted conventional dcs maintain inflammation despite lower glycolysis via mtor signalling and succinate oxidation
url https://doi.org/10.1038/s44324-024-00034-1
work_keys_str_mv AT kaushiksen smrtdepletedconventionaldcsmaintaininflammationdespitelowerglycolysisviamtorsignallingandsuccinateoxidation
AT rashmirekhapati smrtdepletedconventionaldcsmaintaininflammationdespitelowerglycolysisviamtorsignallingandsuccinateoxidation
AT gyanprakashmishra smrtdepletedconventionaldcsmaintaininflammationdespitelowerglycolysisviamtorsignallingandsuccinateoxidation
AT subhasishprusty smrtdepletedconventionaldcsmaintaininflammationdespitelowerglycolysisviamtorsignallingandsuccinateoxidation
AT souryaprakashnayak smrtdepletedconventionaldcsmaintaininflammationdespitelowerglycolysisviamtorsignallingandsuccinateoxidation
AT archanatripathy smrtdepletedconventionaldcsmaintaininflammationdespitelowerglycolysisviamtorsignallingandsuccinateoxidation
AT shwetachaudhary smrtdepletedconventionaldcsmaintaininflammationdespitelowerglycolysisviamtorsignallingandsuccinateoxidation
AT atimuktajha smrtdepletedconventionaldcsmaintaininflammationdespitelowerglycolysisviamtorsignallingandsuccinateoxidation
AT arunitapatra smrtdepletedconventionaldcsmaintaininflammationdespitelowerglycolysisviamtorsignallingandsuccinateoxidation
AT pritimeena smrtdepletedconventionaldcsmaintaininflammationdespitelowerglycolysisviamtorsignallingandsuccinateoxidation
AT shaktiprasadmishra smrtdepletedconventionaldcsmaintaininflammationdespitelowerglycolysisviamtorsignallingandsuccinateoxidation
AT ranjankumarnanda smrtdepletedconventionaldcsmaintaininflammationdespitelowerglycolysisviamtorsignallingandsuccinateoxidation
AT alokkumarmantri smrtdepletedconventionaldcsmaintaininflammationdespitelowerglycolysisviamtorsignallingandsuccinateoxidation
AT bhawnagupta smrtdepletedconventionaldcsmaintaininflammationdespitelowerglycolysisviamtorsignallingandsuccinateoxidation
AT sunilkraghav smrtdepletedconventionaldcsmaintaininflammationdespitelowerglycolysisviamtorsignallingandsuccinateoxidation